Other investigators reported that the hypomethylation status of the neoangiogenic factor ANGPT2 was correlated with shorter overall survival and poor prognosis in CLL patients [43]. This evidence concerns the gene ANGPT2 and B-cell chronic lymphocytic leukemia.